Option chain shows key data for Spectral AI's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Spectral AI.

Spectral AI (NASDAQ:MDAI) Stock, Option Chain

Spectral AI

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

bz_pharma_briefs

News

Health Care

General

MDAI

Spectral AI says DeepView System scored around 87% in judging non-healing tissue compared to 41% by the burn physicians. The image processing algorithm utilizes multispectral imaging, which is trained and tested against a proprietary database of more than 340 billion clinically validated data points.

Spectral AI DeepView System Performs, Plans Product Launch In 2026

movers image

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALEC

CHRO

ELVA

HSAI

IDAI

LAES

LESL

ONCO

PROC

PSTX

QMCO

QUBT

SMTC

WLDS

ZENA

Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket

Screenshot 2024-06-04 at 5.43.27 PM

Biotech

Interview

Revolutionizing Wound Care With Spectral AI - See How This AI Company Is Changing Critical Diagnostics

Spectral AI Inc

Small Cap

Opinion

Press Releases

FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape

Financing

Spectral AI Strengthens Financial Position Ahead of FDA Submission

CORRECTION: Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call

Spectral AI Completes Three Device Installations in Australia

Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System

IPOs

Spectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IP

Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization

Earnings

Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results

FDA Watch: The Quiet Gold Rush in AI-Powered Medical Devices

Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations

Comments

Spectral AI

Spectral AI (MDAI) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell